Rivaroxaban under a generic label can significantly reduce treatment costs for patients, insurers, and government healthcare programs, all while maintaining the efficacy and safety standards ... Jun 03
The stakes are high, the challenges are many, and the rewards could be transformative not just for India, but for global healthcare as well.... Mar 05
India�s CRDMO sector has the potential to revolutionize the pharmaceutical industry. But will the government step up to unlock its full potential?... Feb 27
-Advertisements-